BGP-15 Protects Mitochondria in Acute, Acetaminophen Overdose Induced Liver Injury

Area of Science:

• Hepatology
• Mitochondrial Biology
• Toxicology

Background:

• Acetaminophen (APAP) overdose causes liver damage through c-Jun amino-terminal kinase (JNK) activation, mitochondrial damage, and endoplasmic reticulum (ER) stress.
• BGP-15, a hydroximic acid derivative, shows potential hepatoprotective properties against APAP-induced liver injury.

Purpose of the Study:

• To investigate the protective effects of BGP-15 on mitochondria in acetaminophen (APAP) overdose-induced acute liver injury in mice.
• To elucidate the mechanisms underlying BGP-15's mitochondrial protective action.

Main Methods:

• Administration of APAP to induce acute liver injury in mice.
• Treatment with BGP-15 to assess its protective effects.
• Evaluation of mitochondrial morphology and damage using immunohistochemistry (TOMM20 and autophagy markers).

Main Results:

• BGP-15 treatment preserved mitochondrial morphology and significantly reduced the number of damaged mitochondria in APAP-treated mice.
• Immunohistochemistry revealed a marked decrease in TOMM20 and co-localized autophagy markers in livers of mice treated with BGP-15.
• BGP-15 administration prevented the activation of c-Jun amino-terminal kinase (JNK).

Conclusions:

• BGP-15 demonstrates significant mitochondrial protective effects in acetaminophen-induced acute liver injury.
• The observed protection is attributed to the preservation of mitochondrial integrity and the prevention of JNK activation.
• BGP-15 represents a potential therapeutic agent for managing acetaminophen overdose-induced hepatotoxicity.